摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methyl-3-oxo-4-prop-2-enoxypentanenitrile

中文名称
——
中文别名
——
英文名称
4-Methyl-3-oxo-4-prop-2-enoxypentanenitrile
英文别名
4-methyl-3-oxo-4-prop-2-enoxypentanenitrile
4-Methyl-3-oxo-4-prop-2-enoxypentanenitrile化学式
CAS
——
化学式
C9H13NO2
mdl
——
分子量
167.2
InChiKey
TWVDUWYLQVBAON-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    12
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    50.1
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • FUSED PYRIMIDINE COMPOUNDS AND USE THEREOF
    申请人:MEDIVATION TECHNOLOGIES, INC.
    公开号:US20160068513A1
    公开(公告)日:2016-03-10
    Fused pyrimidine compounds as kinase inhibitors, such as multi-kinase inhibitors, are provided. Fused pyrimidine compounds as IGF-IR inhibitors are provided. Fused pyrimidine compounds that are inhibitors of Trk receptors (e.g., Trk A, Trk B and Trk C) are provided also. The compounds may be used in a method of treating cancer. Pharmaceutical compositions containing a fused pyrimidine compound and a pharmaceutically acceptable carrier are also provided, as are kits containing a fused pyrimidine compound or salt thereof and instructions for use, e.g., in a method of treating cancer.
    提供了作为激酶抑制剂的融合嘧啶化合物,例如多激酶抑制剂。提供了作为IGF-IR抑制剂的融合嘧啶化合物。还提供了抑制Trk受体(例如Trk A,Trk B和Trk C)的融合嘧啶化合物。这些化合物可以用于治疗癌症的方法。还提供了含有融合嘧啶化合物和药用载体的制药组合物,以及包含融合嘧啶化合物或其盐和使用说明的试剂盒,例如用于治疗癌症的方法。
  • US9499519B2
    申请人:——
    公开号:US9499519B2
    公开(公告)日:2016-11-22
  • [EN] FUSED PYRIMIDINE COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS PYRIMIDINE FUSIONNÉS ET LEUR UTILISATION
    申请人:MEDIVATION TECHNOLOGIES INC
    公开号:WO2014105958A2
    公开(公告)日:2014-07-03
    Fused pyrimidine compounds as kinase inhibitors, such as multi-kinase inhibitors, are provided. Fused pyrimidine compounds as IGF-IR inhibitors are provided. Fused pyrimidine compounds that are inhibitors of Trk receptors (e.g., Trk A, Trk B and Trk C) are provided also. The compounds may be used in a method of treating cancer. Pharmaceutical compositions containing a fused pyrimidine compound and a pharmaceutically acceptable carrier are also provided, as are kits containing a fused pyrimidine compound or salt thereof and instructions for use, e.g., in a method of treating cancer.
查看更多